首页> 外文期刊>tzu chi medical journal >Mirtazapine and Bupropion Combined Treatment in Treatment-resistant Depression
【24h】

Mirtazapine and Bupropion Combined Treatment in Treatment-resistant Depression

机译:米氮平和安非他酮联合治疗难治性抑郁症

获取原文
获取原文并翻译 | 示例

摘要

Treatment-resistant depression is a difficult problem in clinical practice. Evidence for the efficacy of newer antidepressants, such as duloxetine and bupropion, is not yet well established. We present a case of treatment-resistant depression with full recovery where a combination of mirtazapine and bupropion was used after a failed response to combined mirtazapine and duloxetine treatment.
机译:难治性抑郁症是临床实践中的一个难题。新型抗抑郁药(如度洛西汀和安非他酮)疗效的证据尚不明确。我们介绍了一例完全康复的难治性抑郁症病例,其中在对米氮平和度洛西汀联合治疗反应失败后,使用了米氮平和安非他酮的组合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号